How AI can be optimised for better healthcare

1. At a Glance

• AI in healthcare refers to deployment of machine-learning/algorithmic tools across diagnosis, clinical documentation, administrative/revenue-cycle operations, and disease surveillance to extend expert knowledge to the point of care [4].
• India faces a structural gap between accumulated medical knowledge and its delivery — limited clinicians, institutions, and connecting systems — making AI's "knowledge-extension" role especially consequential [4].
• Relevant for UPSC as it spans GS-II (health governance, digital public infrastructure) and GS-III (emerging tech, AI ethics) and features India's own national AI-health strategy (SAHI).

2. Why in the News

• A January 2026 McKinsey analysis estimated AI applied to healthcare revenue-cycle operations could cut the "cost to collect" by 30–60% [4].
• India AI Impact Summit 2026: Union Health Minister J.P. Nadda launched SAHI (Strategy for Artificial Intelligence in Healthcare for India) and BODH initiatives to build a "responsible health AI ecosystem" [1].
• US FDA: by January 2025, had authorised over 1,000 AI-enabled medical devices (radiology, cardiology, diagnostics) [4].
• UK NHS: issued guidance in April 2025 on AI-enabled "ambient scribing"; by January 2026 was developing a national adoption programme, with early evidence AI could free up doctors' time by up to a quarter [4].

3. Background & Evolution

• 2021: WHO published "Ethics and governance of artificial intelligence for health" — first comprehensive global guidance, with six consensus principles [3].
• 2021: NITI Aayog released the National Digital Health Mission (NDHM) Strategy Overview, laying groundwork for India's digital health stack [2].
• 2023 (Oct 19): WHO issued considerations for regulation of AI for health [3].
• 2024 (Jan 18): WHO released ethics/governance guidance specifically on large multi-modal models (LMMs) in health, with 40+ recommendations [3].
• 2024 (Oct 14): National Health Authority (NHA)–IIT Kanpur MoU signed to build an open benchmarking platform validating AI health models using Ayushman Bharat Digital Mission (ABDM) ecosystem data [1].
• 2025–26: FDA device authorisations cross 1,000; NHS scribing guidance and national programme; India launches SAHI/BODH at the India AI Impact Summit 2026 [1][4].

4. Core Static Facts

Item	Detail
Nodal Indian body for digital health	National Health Authority (NHA), under Ministry of Health & Family Welfare [1]
Flagship digital health infra	Ayushman Bharat Digital Mission (ABDM) — ~799–860 million digital health IDs created [1]
India's AI-health strategy	SAHI — governance framework/policy roadmap for responsible AI in healthcare, launched at India AI Impact Summit 2026 [1]
Companion initiative	BODH — launched alongside SAHI for the "responsible health AI ecosystem" [1]
Centres of Excellence for AI in health	AIIMS Delhi, PGIMER Chandigarh, AIIMS Rishikesh [1]
Academic partner for AI model validation	IIT Kanpur (MoU with NHA, Oct 2024) [1]
Global regulator benchmark	US FDA — 1,000+ AI-enabled medical devices authorised (Jan 2025) [4]
UK example	NHS ambient AI scribing guidance (April 2025) [4]
Global normative body	WHO — 2021 ethics guidance; 2024 LMM guidance (40+ recommendations, 6 consensus principles) [3]
Economic estimate	McKinsey (Jan 2026): AI can cut healthcare revenue-cycle "cost to collect" by 30–60% [4]

5. Multi-Dimensional Analysis

Economic

• Administrative/revenue-cycle automation offers large, near-term cost savings (30–60% per McKinsey) without direct clinical risk, making it a low-friction entry point for AI adoption in hospitals [4].
• AI-enabled diagnostics can reduce dependence on scarce specialist manpower, indirectly lowering per-patient cost of care in under-served regions.

Social

• India's uneven distribution of trained clinicians means AI-based point-of-care tools could improve equity of access, particularly in rural/tribal and underserved districts [4].
• Risk of a new digital divide if AI tools require infrastructure (internet, devices) unavailable in poorer regions.

Scientific/Technological

• Rapid diffusion: from ~1,000 FDA-cleared AI devices to ambient clinical documentation (NHS) — AI is moving "out of innovation teams into consultations, diagnostics, and hospital operations" [4].
• NHA–IIT Kanpur open benchmarking platform aims to validate model accuracy/safety before scaled deployment [1].

Ethical/Governance

• WHO's 2021 and 2024 guidance flag risks: bias, data privacy, accountability gaps, and the need for human oversight of large multi-modal models [3].
• India's SAHI frames itself explicitly as a "governance framework" — signalling regulation is being built alongside adoption, not after [1].

Administrative

• Implementation depends on interoperable data infrastructure (ABDM) — a federal digital public good that states/private hospitals must plug into [1].
• Centre of Excellence model (AIIMS/PGIMER) is being used to pilot and validate before national scale-up [1].

6. Recent Developments (last 12–18 months)

• Oct 2024: NHA–IIT Kanpur MoU for AI health-model benchmarking on ABDM data [1].
• Jan 2025: US FDA crosses 1,000 authorised AI-enabled medical devices [4].
• Apr 2025: NHS issues guidance on AI ambient scribing [4].
• Jan 2026: NHS developing national ambient-AI adoption programme; McKinsey publishes revenue-cycle AI cost-savings analysis [4].
• 2026 (India AI Impact Summit): Health Minister launches SAHI and BODH [1].
• Mar 2026: PIB document on "Trust, Diversity and Inclusion: AI in Healthcare" [1].

7. Prelims Hooks

• SAHI = Strategy for Artificial Intelligence in Healthcare for India, launched by J.P. Nadda at the India AI Impact Summit 2026 [1].
• BODH is a companion initiative launched alongside SAHI [1].
• NHA signed MoU with IIT Kanpur (Oct 14, 2024) for AI model benchmarking using ABDM data [1].
• Centres of Excellence for AI in healthcare designated: AIIMS Delhi, PGIMER Chandigarh, AIIMS Rishikesh [1].
• ABDM (Ayushman Bharat Digital Mission) has generated ~799–860 million digital health IDs [1].
• US FDA had authorised over 1,000 AI-enabled medical devices by January 2025 [4].
• UK NHS issued AI ambient-scribing guidance in April 2025 [4].
• WHO's first AI-health ethics guidance was published in 2021; six consensus principles were laid down [3].
• WHO's guidance on large multi-modal models in health was released January 18, 2024, with 40+ recommendations [3].
• McKinsey (Jan 2026) estimates AI could cut healthcare "cost to collect" (revenue cycle) by 30–60% [4].
• Nodal Indian agency for digital health infrastructure: National Health Authority (NHA), under MoHFW [1].
• NITI Aayog released the National Digital Health Mission Strategy Overview in 2021 [2].

8. Mains Relevance

• GS-II: Health — issues relating to development and management of the Health sector; e-governance/digital initiatives.
• GS-III: Science & Technology — developments in AI and their applications/effects in everyday life; awareness in fields of IT.
• Possible question stems: 1. "Discuss the potential and limitations of Artificial Intelligence in bridging India's healthcare access gap. Refer to recent government initiatives." (GS-III, 15 marks) 2. "Examine the ethical and governance challenges associated with the deployment of AI in clinical decision-making, with reference to WHO guidelines." (GS-II/GS-IV) 3. "How can digital public infrastructure such as ABDM be leveraged to build a responsible AI ecosystem in Indian healthcare?" (GS-II, 10 marks)

9. Related Topics to Study Next

• Ayushman Bharat Digital Mission (ABDM) — the data backbone enabling AI-health applications in India.
• National Digital Health Mission (NDHM) — precursor/parent strategy to ABDM.
• WHO Ethics and Governance of AI for Health guidance (2021, 2024) — global normative framework.
• Digital Public Infrastructure (DPI) — India's broader model (Aadhaar, UPI, ABDM) of which health-AI is one arm.
• Telemedicine and e-Sanjeevani — complementary tech-driven health access initiatives.
• National AI Strategy / IndiaAI Mission — the umbrella AI policy under which sectoral strategies like SAHI sit.
• Data Protection/DPDP Act, 2023 — governs health data privacy relevant to AI training/deployment.
• Tuberculosis elimination programme (NTEP) — cited use-case for AI-based chest X-ray screening.

10. Common Errors / Trap Areas

• Do not confuse SAHI (Strategy for AI in Healthcare for India, MoHFW/NHA) with generic "IndiaAI Mission" (MeitY) — different ministries and scope.
• ABDM digital health ID figures are frequently updated (~799 million as of Aug 2025, cited as 860 million more recently) — don't fix a single number as permanent; note approximate ranges.
• WHO's 2021 guidance and 2024 LMM guidance are two distinct documents — do not merge their recommendation counts or dates.
• NHA is the implementing body for ABDM/AI-health digital infrastructure, not NITI Aayog (NITI Aayog authored the original 2021 strategy overview, but implementation shifted to NHA).
• FDA's "1,000+ AI devices" figure is a US regulatory statistic, not an India-specific number — avoid conflating global and domestic scale in answers.